CENPU and breast carcinoma: In Banin Hirata BK et al.’s research (18), microarray analysis was performed using Affymetrix U133A microarray in 200 breast cancer patients, and found that CENP-U gene was significant over-expressed in recurrent patients compared with no-recurrent ones, indicating that CENP-U could be a prognostic and predictive marker for breast cancer patients.